Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies

Stefan Kasper(Essen University Hospital), Thomas Fischer(Otto-von-Guericke University Magdeburg)
Blood Cancer Journal
March 9, 2012
10.1038/bcj.2012.5
Cited by 85

Related Papers

JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
|Journal of Clinical Investigation|2018|135
Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
|Cell Death and Disease|2014|27
Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells
|PLoS ONE|2012|21